Phathom Pharmaceuticals, Inc. (PHAT)
USD 2.76
(-17.86%)
USD 2.76
(-17.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -137.58 Million | -146.53 Million | -148.61 Million | -69.68 Million | -36.51 Million | -1.02 Million |
| Net Income | -201.59 Million | -197.72 Million | -143.88 Million | -129.06 Million | -255.13 Million | -1.28 Million |
| Depreciation & Amortization | 575 Thousand | 620 Thousand | 521 Thousand | 323 Thousand | 8000.00 | - |
| Deferred income taxes | 4.66 Million | - | - | -95 Thousand | 96.27 Million | - |
| Stock-based compensation | 45.02 Million | 24.13 Million | 16.81 Million | 5.84 Million | 406 Thousand | - |
| Change in working capital | -13.64 Million | 5.43 Million | -27.47 Million | 51.71 Million | -9.52 Million | 215 Thousand |
| Other non-cash items | 27.38 Million | 21 Million | 5.4 Million | 1.59 Million | 131.45 Million | 50 Thousand |
| Investing Cash Flow | -1.63 Million | -1.04 Million | -328 Thousand | -1.04 Million | -25.25 Million | - |
| Investments in PPE | -1.63 Million | -1.04 Million | -328 Thousand | -1.04 Million | -25.25 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.65 Million | -1.17 Million | -330 Thousand | -1.18 Million | -25.11 Million | - |
| Financing Cash Flow | 367.58 Million | 120.04 Million | 44.7 Million | 114.45 Million | 304.64 Million | 1.9 Million |
| Debt repayment | -211.99 Million | -95.44 Million | -54.12 Million | -25 Million | -113.17 Million | -1.9 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 155.58 Million | 24.59 Million | 1.29 Million | 88.83 Million | 191.47 Million | 2000.00 |
| Other Financing Activities | 172.67 Million | 190.89 Million | 97.54 Million | 50.62 Million | 226.34 Million | 1.9 Million |
| Accounts receivables | -1.63 Million | - | - | - | - | - |
| Accounts payables | 6.41 Million | 8.67 Million | -9.79 Million | 24 Million | 2.26 Million | 225 Thousand |
| Inventory | -9.44 Million | - | - | - | - | - |
| Other working capital | -8.97 Million | -3.24 Million | -17.68 Million | 27.7 Million | -11.78 Million | -10 Thousand |
| Cash at beginning of period | 155.89 Million | 183.41 Million | 287.49 Million | 243.76 Million | 879 Thousand | - |
| Cash at end of period | 384.25 Million | 155.89 Million | 183.25 Million | 287.49 Million | 243.76 Million | 879 Thousand |
| Capital Expenditure | -1.63 Million | -1.04 Million | -328 Thousand | -1.04 Million | -25.25 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 228.36 Million | -27.52 Million | -104.23 Million | 43.73 Million | 242.88 Million | 879 Thousand |
| Free Cash Flow | -139.21 Million | -147.57 Million | -148.94 Million | -70.72 Million | -61.76 Million | -1.02 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -91.44 Million | -82.85 Million | -79.57 Million | -201.59 Million | -43.24 Million | -40.96 Million |
| Depreciation & Amortization | 197 Thousand | 214 Thousand | 185 Thousand | 575 Thousand | 121 Thousand | 123 Thousand |
| Deferred income taxes | - | - | - | 4.66 Million | - | - |
| Stock-based compensation | 6.09 Million | 5.62 Million | 24.58 Million | 45.02 Million | 6.14 Million | 7.25 Million |
| Change in working capital | -626 Thousand | -7.02 Million | 676 Thousand | -13.64 Million | -2.41 Million | 4.43 Million |
| Other non-cash items | 19.58 Million | 28.74 Million | 10.32 Million | 27.38 Million | 7.48 Million | 6.95 Million |
| Investing Cash Flow | -46 Thousand | -40 Thousand | -475 Thousand | -1.63 Million | -939 Thousand | -6000.00 |
| Investments in PPE | -46 Thousand | -40 Thousand | -475 Thousand | -1.63 Million | -939 Thousand | -6000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -47 Thousand | -1.65 Million | -1.65 Million | - | - |
| Financing Cash Flow | 24.77 Million | 9.9 Million | 211.99 Million | 367.58 Million | 13 Thousand | 141.5 Million |
| Debt repayment | -24.75 Million | -9.9 Million | -211.99 Million | -211.99 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 21 Thousand | - | -141.4 Million | 155.58 Million | 13 Thousand | 141.5 Million |
| Other Financing Activities | 21 Thousand | 9.9 Million | 211.99 Million | 172.67 Million | 13 Thousand | 141.5 Million |
| Accounts receivables | -6.99 Million | -2.24 Million | -1.63 Million | -1.63 Million | 111.00 | - |
| Accounts payables | 8.69 Million | -5.01 Million | 10.26 Million | 6.41 Million | 4.59 Million | 2.85 Million |
| Inventory | 268 Thousand | -416 Thousand | -9.33 Million | -9.44 Million | -111.00 | - |
| Other working capital | -2.58 Million | 653 Thousand | 1.37 Million | -8.97 Million | -7 Million | 1.57 Million |
| Cash at beginning of period | 322.22 Million | 381.39 Million | 216.53 Million | 155.89 Million | 249.37 Million | 130.07 Million |
| Cash at end of period | 276.23 Million | 322.22 Million | 384.25 Million | 384.25 Million | 216.53 Million | 249.37 Million |
| Capital Expenditure | -46 Thousand | -40 Thousand | -475 Thousand | -1.63 Million | -939 Thousand | -6000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -45.99 Million | -59.16 Million | 167.72 Million | 228.36 Million | -32.84 Million | 119.29 Million |
| Free Cash Flow | -70.76 Million | -69.06 Million | -44.27 Million | -139.21 Million | -32.85 Million | -22.2 Million |
0KIT
9684
002651
BCPPF
KTF
NEMKY